Evidence for efficacy is based on the results from the TROPION-Lung05 and TROPION-Lung01 studies
Home World News FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell Lung...
Evidence for efficacy is based on the results from the TROPION-Lung05 and TROPION-Lung01 studies
